Pharmaceutical

Opinion: Why involuntary treatment for addiction is a d...

Involuntary treatment might be worth it if it worked — but evidence strongly sug...

STAT+: Maryland pushes first-of-its-kind bill to promot...

"We believe the best way to end animal testing is to pump up alternative R&D tes...

STAT+: Pharmalittle: Weight-loss drug makers lobby Cong...

Weight-loss drug makers are lobbying Congress to grant them access to Medicare f...

STAT+: Bluebird submits sickle cell gene therapy to FDA...

Gene therapy developer Bluebio Bio said it has submitted a long-awaited applicat...

STAT+: How a small hospital in Nebraska has thrived thr...

Great Plains Health CEO Ivan Mitchell spoke with STAT about how his Nebraska hos...

Opinion: How small vaccine stockpiles can stop outbreak...

If we can’t get this right for known diseases like Marburg, what hope do we have...

Q&A: Chronicling the failures of the U.S. response to C...

A new book on the U.S. response to the Covid-19 pandemic paints a picture of a c...

Opinion: How journalists can cover RFK Jr.’s antivax pr...

Donald Trump showed us how dangerous it is to dismiss a conspiracy theorist with...

STAT+: ‘A tug of war’: Europe braces for new legislatio...

The European Commission on Wednesday will soon release draft legislation that co...

STAT+: Supreme Court maintains access to abortion pill ...

The U.S. Supreme Court on Friday ruled 7-2 that a commonly used abortion pill co...

Dying patients protest looming telehealth crackdown

The DEA wants to reinstate requirements that doctors see patients in person befo...

STAT+: Epic and Microsoft’s AI collaboration, Amazon an...

In the latest edition of STAT's Health Tech newsletter: Epic and Microsoft's AI ...

STAT+: Biden to tap head of National Cancer Institute t...

President Biden will nominate oncologist Monica Bertagnolli, director of the Nat...

China clears CARsgen’s CT041 IND for pancreatic cancer

CT041 targets CLDN18.2 positive solid tumours by focusing on gastric cancer/gast...

AZ to terminate once-daily cotadutide program to focus ...

In a statement emailed to Endpoints News, AstraZeneca (AZ) disclosed intentions ...

Twist Bioscience and Astellas team up for antibody disc...

Astellas Pharma will use Twist Bioscience’s VHH antibody libraries to conduct re...